| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.19B | +8.7% |
| Cost of Revenue | $231.0M | +32.8% |
| Gross Profit | $957.0M | +4.1% |
| R&D Expense | $107.0M | -7.8% |
| SG&A Expense | $618.0M | +8.6% |
| Operating Income | $32.0M | +120.5% |
| Interest Expense | $32.0M | +18.5% |
| Pre-tax Income | $14.0M | +109.4% |
| Income Tax | $11.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $319.0M | +0.9% |
| Short-term Investments | $1.0M | -98.9% |
| Accounts Receivable | $254.0M | +0.0% |
| Inventory | $178.0M | +31.9% |
| Current Assets | $839.0M | -33.7% |
| Total Assets | $1.32B | -25.1% |
| Current Liabilities | $939.0M | -27.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $36.0M | +112.0% |
| Capital Expenditures | $29.0M | +262.5% |
| Investing Cash Flow | $69.0M | +172.6% |
| Financing Cash Flow | -$102.0M | -59.4% |
| Free Cash Flow | $7.0M | +102.3% |
| +155.0% |
| Net Income | $2.0M | +101.6% |
| EPS (Basic) | $0.02 | +102.1% |
| EPS (Diluted) | $0.02 | +102.1% |
| Long-term Debt |
| $315.0M |
| +32.9% |
| Total Liabilities | $1.67B | -14.5% |
| Stockholders' Equity | -$348.0M | -82.2% |